Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication
Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 20, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-Based Devices ("EBD"), injectables, and other complementary solutions, today announced China's National Medical Products Administration ("NMPA") had formally accepted the registration application for Profhilo's facial indication in September. This milestone...
Colossal to Repatriate Rare Moa Egg to Aotearoa (New Zealand)
Colossal secured one of the world's few surviving moa eggs and will entrust it to New Zealand-based moa de-extinction program partners, to ensure the egg returns to its rightful land and people. CHRISTCHURCH, New Zealand and DALLAS, Oct. 20, 2026 /PRNewswire/ -- Colossal Biosciences, the world's first de-extinction company, today announced...
Distinguished clinician-scientist Professor Marcus Ong is first Singaporean emergency medicine physician elected to National Academy of Medicine, USA
SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- Professor Marcus Ong Eng Hock, Senior Consultant, Department of Emergency Medicine, Singapore General Hospital (SGH), has become the first Emergency Medicine specialist from Singapore to be elected to the United States National Academy of Medicine (NAM). He is the fourth Singaporean to join the Academy. ...
Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity
- Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combinations. - ASC36o, a once-weekly oral amylin receptor peptide agonist, is the most advanced drug candidate of Ascletis' once-weekly oral peptide pipeline and its Phase I study has started in the U.S. - ASC36o demonstrated a half-life of...
WuXi AppTec Receives Frost & Sullivan’s Global Company of the Year Recognition in CRDMO for Tenth Consecutive Year
SHANGHAI, Oct. 20, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & Sullivan highlighted WuXi AppTec's integrated CRDMO model, which enables the company to support customers across the...
Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership
Integrated capabilities, global capacity, and customer-centric innovation strengthen WuXi AppTec's position in the evolving contract research, development, and manufacturing (CRDMO) landscape. SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Frost & Sullivan has awarded WuXi AppTec the 2026 Global Company of the Year Recognition in the CRDMO industry for its strong performance in enabling innovation, operational excellence, and customer impact. Frost...
Can we produce low-cost omega-3s without relying on fish?
GOLD COAST, Australia, Oct. 20, 2026 /PRNewswire/ -- Southern Cross University researchers are aiming to halve the cost of producing omega-3 supplements to make these essential nutrients more accessible to pregnant women and infants in low-income countries, backed by the University's first-ever grant from The Gates Foundation. The research...
Vitaceuticals Launches MagZorb Joint Ease with NEM Nationwide
Australians crack 6.87 billion eggs a year. Joint health research says we're throwing away the best bit. SYDNEY, Oct. 20, 2026 /PRNewswire/ -- The paper-thin membrane inside every eggshell has been studied in human clinical trials for joint pain and stiffness. Now it's on supermarket shelves nationwide. Natural eggshell membrane, the thin film most Australians throw...
CHANDO Group Showcases Chinese Beauty Science at COSMETIC 360, Debuts Fatigue-Aging Research on Global Stage
PARIS, Oct. 19, 2026 /PRNewswire/ -- CHANDO Group featured its five brands and latest advances in cosmetic ingredient research at the 12th edition of COSMETIC 360, organized by Cosmetic Valley and held at the Louvre in Paris on October 14–15. As a representative of China's beauty industry, the Group also participated in the 2026 International Cosmetics Innovation Summit...
Versiti becomes 10th U.S. blood center to adopt FDA-cleared automation from Terumo Blood and Cell Technologies
Automated whole blood processing will expand platelet production capacity and help meet growing hospital demand LAKEWOOD, Colo. and MILWAUKEE, Oct. 19, 2026 /PRNewswire/ -- Versiti has become the 10th U.S. blood center to adopt the Reveos™ Automated Blood Processing System from Terumo Blood and Cell Technologies (Terumo BCT). Combined with the...
